Menu

Precision Neuro: Restoring Freedom Through Brain-Computer Interfaces

The Next Generation of Neural Engineering

Published on

Read

2 min

Alumni Ventures portfolio company Precision Neuro is developing a brain-computer interface (BCI) installed via a patented minimally invasive insertion procedure. Precision’s BCI employs a thin film microelectrode array that conforms to the brain’s cortex without harming the surrounding tissue. This allows thousands of channels to be delivered anywhere on the brain’s surface.

Precision Neuro’s Brain-Computer Interface

Precision Neuro’s Layer 7 Cortical Interface System is engineered to map a large area of the brain’s surface at resolutions hundreds of times more detailed than typical arrays used in neurosurgical procedures. Learn more about the company’s mission to restore meaningful function to millions of people suffering from neurological illnesses and disorders.

See video policy below.

Reserve Your Spot in Deep Tech Fund 4

We are seeing strong interest in our Deep Tech Fund. If interested, we recommend securing a spot promptly.

Investors in the fund will own a portfolio of high-tech game-changers and disruptive business models using advanced science and engineering to tackle the toughest and potentially most lucrative tech challenges.

Max Accredited Investor Limit: 249
Deadline to Join: December 31, 2023

A New Kind of Brain-Computer Interface

In 2019 alone, there were nearly 10 million deaths and 349 million disability-adjusted life years due to neurological disorders like Parkinson’s, epilepsy, and multiple sclerosis. Because of their severity and lack of treatment options, neurological conditions can be hard to diagnose and harder to effectively treat.

Legacy BCI technology typically relies on penetrating electrode arrays to function. In other words, the installation of the electrode itself causes brain tissue damage. While reversal of the procedure is possible, it is more invasive and subject to a higher risk of complications due to the invasive approach.

Precision’s BCI takes a different approach. Rather than physically penetrating the patient’s brain, Precision’s BCI is instead a smooth, flexible sensor array thinner than a strip of tape that is carefully positioned on top of the patient’s brain, between the brain tissue and the skull. Dubbed the Layer 7 Cortical Interface, the array not only allows for a less invasive insertion for patients but is capable of capturing vastly more amounts of data over a larger proportion of the cortex than other interfaces, while also maintaining the capability to both read and stimulate regions of the brain.

What We Like About Precision

  • Home

    World Class Team of Neuroscientists

    Precision features a team of talented and knowledgeable neuroscientists, several of whom helped co-found Neuralink, the brain-computer interface startup founded by Elon Musk.
  • Home

    Unique Technology and IP

    Precision has developed a minimally invasive approach capable of implanting millions of electrodes without causing damage to brain tissue, compared to other riskier interfaces.
  • Home

    Rapid Progress

    Within a year of launch, the company has validated its system in multiple large-animal studies, developed a portfolio of over 20 patents, and charted a regulatory pathway to obtain FDA clearance in the next few years.

How We Are Involved

116 Street Ventures (for the Columbia community) sponsored our investment in Precision’s $41 million Series B led by Forepont Capital Partners. Several other AV funds also participated in the round:

View Fund Performance
Login to our secure data room.

Schedule a Call to Speak with Us
Ask questions important to you.

Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.

Written by

AV Communications Team

Alumni Ventures is a network-powered VC firm that helps accredited individuals invest in venture capital.

LinkedIn
Twitter
Facebook
Tagged with

Follow us

AV Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: [email protected]

Press inquiries: [email protected]

603-518-8112

Follow us

Neither Alumni Ventures nor any of its funds are sponsored by, affiliated with, or otherwise endorsed by any university. For further details see our Legal & Privacy Policy.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose. Offers to purchase securities are only made through formal offering documents, which describe risks (which are significant), terms, and other important information that must be considered before an investment decision is made. To see Important Disclosure Information, visit: https://av-funds.com/disclosures.

Testimonial/Endorsement Policy: Testimonials/Endorsements were provided by the participants without compensation, but each participant has a relationship with Alumni Ventures (AV) from which they benefit. All views expressed are the individual’s own and do not represent the experience of all AV fund investors or companies in which AV funds invest. Please note that testimonials are no guarantee of future performance or success. Any provider of an endorsement that is affiliated with a portfolio company Alumni Ventures has received investment funding from AV, and may in the future seek and/or receive additional funding from AV. This circumstance constitutes a conflict of interest. Providers of testimonials or endorsements were not chosen at random or according to any objective basis, but rather on the basis of their relationship with AV.

Investor Portal Update Policy: Investor portfolio data is updated once per quarter in the AV Investor Portal.

Alumni Ventures is America’s largest VC firm for individual investors based on the combination of total capital raised, number of investments, and number of investors of leading VC firms as reported by Pitchbook and other publicly available information reviewed by AV.

(1)The aggregate performance of the AV venture funds is not necessarily representative of the performance of any particular AV venture fund or the experiences of any individual AV investor. All investment involves risk, including risk of loss. Not all venture capital investments will be successful. Past performance is not necessarily reflective of future results, and achievement of investment objectives, including preservation of principal, cannot be guaranteed. (2) IRR for AV Funds includes Uninvested Cash, Unrealized Investments, and Amounts Distributed to Investors. IRR for AV Funds is net of all management fees and incentive allocations payable to AV, including incentive allocations accrued due to unrealized gains on investments held by AV Funds.  Incentive allocations actually paid from unrealized gains may differ in the future due to possible changes in valuation prior to liquidation.  For additional information, please see here. The IRR shown for Nasdaq Composite, S&P 500, and Russell 2000 indices are gross of fees because indices are not managed investments. It is not possible to invest directly in an index.

To see additional risk factors and investment considerations, visit: https://av-funds.com/disclosures

© 2023, Alumni Ventures. All rights reserved.